$2.59 Billion is the total value of Artal Group S.A.'s 99 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BNTX | New | BIONTECH SEsponsored ads | $89,041,000 | – | 2,628,130 | +100.0% | 3.44% | – |
| PYPL | New | PAYPAL HLDGS INC | $21,634,000 | – | 200,000 | +100.0% | 0.84% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $12,572,000 | – | 850,000 | +100.0% | 0.49% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $10,222,000 | – | 50,000 | +100.0% | 0.40% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCcall | $8,455,000 | – | 100,000 | +100.0% | 0.33% | – |
| BPMC | New | BLUEPRINT MEDICINES CORPcall | $8,011,000 | – | 100,000 | +100.0% | 0.31% | – |
| CLVS | New | CLOVIS ONCOLOGY INCcall | $7,819,000 | – | 750,000 | +100.0% | 0.30% | – |
| IMUX | New | IMMUNIC INC | $6,111,000 | – | 630,019 | +100.0% | 0.24% | – |
| PRTA | New | PROTHENA CORP PLC | $4,749,000 | – | 300,000 | +100.0% | 0.18% | – |
| FATE | New | FATE THERAPEUTICS INCcall | $3,914,000 | – | 200,000 | +100.0% | 0.15% | – |
| KRTX | New | KARUNA THERAPEUTICS INC | $3,767,000 | – | 50,000 | +100.0% | 0.15% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $2,930,000 | – | 199,700 | +100.0% | 0.11% | – |
| CRIS | New | CURIS INC | $2,550,000 | – | 1,500,000 | +100.0% | 0.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.